Epidemiology and antimicrobial resistance patterns of Aeromonas species in Europe, 2020-2024 (AEuROMONAS) Matteo Boattini, Paulo Bastos, Konstantina Gartzonika, Eirini Christaki, Viktoria Eirini Mavromanolaki, Sofia Maraki, Anastasia Spiliopoulou, Nikolaos Giormezis, Gergana Lengerova, Yordan Kalchev, Ana Budimir, Branka Bedenić, Zana Rubic, Antonija Saskor, Karla Milanovic, Monica Licker, Corina Musuroi, Emese Juhász, Katalin Kristóf, Mateja Pirs, Ivana Velimirovic, Michael Berktold, Adriána Krajčíková, Anezka Gryndlerova, Pavel Drevinek, Miroslava Htoutou Sedláková, Milan Kolář, Monika Brzychczy-Wloch, Aldona Olechowska-Jarząb, Małgorzata Brauncajs, Filip Bielec, Dominika Seliga-Gąsior, Edyta Podsiadly, Kristian Riesbeck, Hanna-Sofia Andersson, Tone Tønjum, Johan Christian Berild, Truls Michael Leegaard, Asger Nellemann Rasmussen, Kristian Schønning, Stefan Glöckner, Jürgen Rödel, Sara Posadas-Cantera, Mohamed Tarek Badr, Tim Kintzinger, Frieder Schaumburg, Philipp Thelen, Axel Hamprecht, Anna Dudakova, Jonathan Jantsch, Katharina Hoffmann, Achim J. Kaasch, Damien Jacot, Gilbert Greub, Jessica Landi, Simone Ambretti, Sara Comini, Sofia Chiatamone Ranieri, Enrica Serretiello, Gianluigi Franci, Teresa Fasciana, Rogier Schade, Erlangga Yusuf, Stefanie van Kleef van Koeveringe, Sarah Vandamme, Alexia Verroken, Hector Rodriguez-Villalobos, Gregory Strubbe, Stien Vandendriessche, Pauline Rabeau, Stéphane Corvec, Damien Dubois, Pauline Floch, Delphine Chainier, Olivier Barraud, Assaf Mizrahi, Célia Bacho, Coralie Bouchiat, Tayssir Fatah, Hélène Marchandin, Vincent Jean-Pierre, Saied Ali, Sinead O’ Donnell, Maeve Doyle, Zachary Ramsamaroo, Clarice Egan, Sinead McNicholas, Kristján Orri Helgason, Betigül Öngen, Bahar Akgün Karapınar, Özlem Oyardi, Burak Aksu, Javier Colomina-Rodriguez, Ignacio Torres, Raul Gilarranz Luengo, Maria Nieves Larrosa Escartín, Maria Belen Viñado Perez, Ana Verónica Halperin, Rafael Cantón, Miguel Seruca, Vasco Santos Mendes, Yuliya Volovetska, José Melo Cristino, Cristina Costa, Gabriele Bianco Diagnostic Microbiology and Infectious Disease, 2026
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: A valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections? Milo Gatti, Cecilia Bonazzetti, Benedetta Secci, Beatrice Giorgi, Matteo Rinaldi, Pier Giorgio Cojutti, Simone Ambretti, Antonio Siniscalchi, Tommaso Tonetti, Pierluigi Viale, Federico Pea International Journal of Antimicrobial Agents, 2026 • Meropenem-vaborbactam is a first-line option for treating KPC-producing infections • CI administration allowed to attain aggressive joint PK/PD target in 96.4% of cases • Microbiological failure occurred in 20.5% of cases and only two developed resistance • CRRT and intrabdominal infections emerged as independent predictors of failure To assess whether attaining an aggressive joint pharmacokinetic/pharmacodynamic (PK/PD) target of therapeutic drug monitoring (TDM)-guided continuous infusion (CI) meropenem-vaborbactam monotherapy may be a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections. This retrospective cohort study was performed in patients receiving CI meropenem-vaborbactam monotherapy for KPC-producing Enterobacterales infections and undergoing real-time TDM. Free fractions of plasma steady-state concentrations ( f C ss ) of meropenem and vaborbactam were calculated according to a protein binding of 2% and 33%, respectively. Aggressive joint PK/PD target attainment was defined as a meropenem f C ss /MIC ratio >4 coupled with a vaborbactam free area under time-to-concentration curve ( f AUC)/target concentration (C T ) ratio >24. Multivariate analysis was performed for assessing potential independent predictors of microbiological failure. Overall, 55 patients were included. Aggressive joint PK/PD target of meropenem-vaborbactam was attained in 96.3% (53/55) of cases. Among 44/55 patients having follow-up cultures (80.0%), 9 experienced microbiological failure (20.5%), and 2 developed 90-day resistance (4.5%). Continuous renal replacement therapy (OR 15.00; 95%CI 1.75–128.40; p=0.013) and intrabdominal infection (OR 10.00; 95%CI 1.36–73.33; p=0.024) emerged as independent predictors of microbiological failure. Aggressive joint PK/PD target was non-attained more frequently among patients having microbiological failure than in those having microbiological eradication (22.2% vs. 0.0%; p=0.038), although not statistically significant at multivariate analysis. Our findings suggest that a TDM-guided monotherapy of documented KPC-producing Enterobacterales infections focused on aggressive joint PK/PD target attainment with CI meropenem-vaborbactam could represent a valuable strategy either for granting microbiological cure and for counteracting resistance development.
Rectal carriage of antimicrobial resistant Enterobacteriaceae among MSM using HIV pre-exposure prophylaxis (PrEP): A cross-sectional study in Italy Leonardo Calza, Marielle Ezekielle Djusse, Claudio Foschi, Tiziana Lazzarotto, Antonella Marangoni, Simone Ambretti International Journal of STD and AIDS, 2026 Background Men who have sex with men (MSM) receiving HIV pre-exposure prophylaxis (PrEP) are often exposed to repeated antimicrobials due to a high burden of sexually transmitted infections (STIs). These factors may contribute to the selection of antimicrobial resistant bacteria within the intestinal microbiota. This study aimed to investigate the prevalence of antimicrobial resistance (AMR) among Enterobacteriaceae isolated from rectal swabs of MSM receiving PrEP and to assess possible associations with behavioral and PrEP-related variables. Methods In this cross-sectional study, rectal swabs were collected from MSM receiving PrEP who had no gastrointestinal symptoms and were attending the Infectious Diseases Clinic of the ‘IRCCS Azienda Ospedaliero-Universitaria di Bologna’ (Italy) for routine STI screening. The same anorectal specimens were used for culture-based isolation, and antimicrobial susceptibility testing of Enterobacteriaceae. Behavioral and clinical data were collected through structured questionnaires. Results A total of 126 Enterobacteriaceae isolates , predominantly Escherichia coli (n = 79; 63%) and Klebsiella spp. (n = 35; 28%), were recovered from 89 of the 92 subjects enrolled. Nearly three-quarters of participants reported antimicrobial use in the previous 12 months, and almost one quarter in the month preceding enrolment. Overall, 40% and 39% of participants reported Chlamydia trachomatis and Neisseria gonorrhoeae , respectively, within the previous two years. Considering all Enterobacteriaceae isolates, resistance to sulfamethoxazole/trimethoprim was the most frequent, followed by ciprofloxacin; resistance to third-generation cephalosporins ranged from 5% to 8%. Resistance to piperacillin/tazobactam was rare (2%), and no carbapenem-resistant isolates were detected. Although not statistically significant, participants reporting recent antibiotic use were more likely to harbor resistant strains across all antimicrobial classes. Conclusions Repeated antimicrobial exposure for STI management may shape intestinal resistance patterns of Enterobacteriaceae among MSM receiving PrEP. Our findings support the need for continued AMR monitoring and targeted antimicrobial stewardship interventions in this population.
Minor non-fermenting Gram-negative bacilli in Europe, 2020–2024 (MINOFEu) Gabriele Bianco, Paulo Bastos, Konstantina Gartzonika, Eirini Christaki, Viktoria Eirini Mavromanolaki, Sofia Maraki, Anastasia Spiliopoulou, Nikolaos Giormezis, Gergana Lengerova, Yordan Kalchev, Ana Budimir, Branka Bedenić, Zana Rubic, Antonija Saskor, Karla Milanovic, Monica Licker, Corina Musuroi, Emese Juhász, Katalin Kristóf, Mateja Pirs, Ivana Velimirovic, Michael Berktold, Adriána Krajčíková, Anezka Gryndlerova, Pavel Drevinek, Miroslava Htoutou Sedláková, Milan Kolář, Monika Brzychczy-Wloch, Aldona Olechowska-Jarząb, Małgorzata Brauncajs, Filip Bielec, Dominika Seliga-Gąsior, Edyta Podsiadly, Kristian Riesbeck, Hanna-Sofia Andersson, Tone Tønjum, Johan Christian Berild, Truls Michael Leegaard, Asger Nellemann Rasmussen, Kristian Schønning, Stefan Glöckner, Jürgen Rödel, Sara Posadas-Cantera, Mohamed Tarek Badr, Tim Kintzinger, Frieder Schaumburg, Philipp Thelen, Axel Hamprecht, Anna Dudakova, Jonathan Jantsch, Katharina Hoffmann, Achim J. Kaasch, Damien Jacot, Gilbert Greub, Jessica Landi, Simone Ambretti, Sara Comini, Sofia Chiatamone Ranieri, Enrica Serretiello, Gianluigi Franci, Teresa Fasciana, Rogier Schade, Erlangga Yusuf, Stefanie van Kleef-van Koeveringe, Sarah Vandamme, Alexia Verroken, Hector Rodriguez-Villalobos, Gregory Strubbe, Stien Vandendriessche, Pauline Rabeau, Stéphane Corvec, Damien Dubois, Clémence Massip, Delphine Chainier, Olivier Barraud, Assaf Mizrahi, Célia Bacho, Coralie Bouchiat, Tayssir Fatah, Hélène Marchandin, Vincent Jean-Pierre, Saied Ali, Sinead O’Donnell, Maeve Doyle, Zachary Ramsamaroo, Clarice Egan, Sinead McNicholas, Kristján Orri Helgason, Betigül Öngen, Bahar Akgün Karapınar, Özlem Oyardı, Burak Aksu, Javier Colomina-Rodriguez, Ignacio Torres, Raul Gilarranz Luengo, Maria Nieves Larrosa Escartín, Maria Belen Viñado Perez, Ana Verónica Halperin, Rafael Cantón, Miguel Seruca, Vasco Santos Mendes, Yuliya Volovetska, José Melo Cristino, Cristina Costa, Matteo Boattini International Journal of Antimicrobial Agents, 2026
Unraveling Cefiderocol Resistance in NDM- and OXA-48-like Co-Producing Klebsiella pneumoniae Isolates Through Integrated Genomic and Phenotypic Analysis Simone Ambretti, Raul Cetatean, Benedetta Secci, Jessica Landi, Alessia Cantiani, Claudio Foschi Antibiotics, 2026 Background/Objectives: The co-production of New Delhi metallo-β-lactamases (NDM) and OXA-48-like carbapenemases in Klebsiella pneumoniae represents a major therapeutic challenge due to extensive drug resistance and limited treatment options. This study aimed to investigate the molecular epidemiology, resistance profiles, and mechanisms associated with reduced susceptibility to cefiderocol in clinical isolates co-producing NDM and OXA-48-like carbapenemases. Methods: A total of 45 clinical K. pneumoniae isolates collected in healthcare settings in Northern Italy were analyzed. Antimicrobial susceptibility testing, including cefiderocol and aztreonam/avibactam, was performed according to EUCAST guidelines. Whole-genome sequencing was used to characterize sequence types, resistance determinants, virulence factors, plasmid replicons, and phylogenetic relationships. Mutations in iron uptake and transport genes were investigated in cefiderocol-resistant isolates. Results: Most isolates belonged to the high-risk clone ST147 (44/45) and were grouped into three main phylogenetic clusters. The isolates exhibited extensive multidrug resistance, with universal susceptibility only for aztreonam/avibactam. Cefiderocol resistance was observed in 42.2% of isolates and was unevenly distributed across the phylogeny. Mutations in iron uptake genes, particularly cirA and chrA, were identified in the majority of resistant isolates, although several strains retained wild-type sequences, indicating heterogeneous resistance mechanisms. Comparative phylogenetic analysis demonstrated close relatedness to international isolates, suggesting the global dissemination of related lineages. Conclusions: NDM- and OXA-48-like carbapenemase co-producing K. pneumoniae isolates are characterized by clonal dissemination, complex resistance profiles, and emerging cefiderocol resistance driven by multifactorial mechanisms. The preserved activity of aztreonam/avibactam highlights its potential as a key therapeutic option against these high-risk pathogens.
Genomic characterization of sexually transmitted Trichophyton mentagrophytes genotype VII causing genital dermatophytosis in Italy Valeria Gaspari, Giulia Lombardi, Claudio Foschi, Donatella Lombardo, Raul Cetatean, Andrea Liberatore, Eva Caterina Borgatti, Jessica Landi, Benedetta Secci, Gionathan Orioni, Tiziana Lazzarotto, Simone Ambretti Medical Mycology, 2026 Dermatophytes are among the most common causes of superficial fungal infections worldwide. In recent years, an increasing number of cases of sexually transmitted dermatophytosis have been reported in Europe, mainly associated with Trichophyton mentagrophytes genotype VII. Genomic data on circulating strains remain limited, particularly in Southern Europe. In this study, we described three cases of sexually transmitted dermatophytosis caused by T. mentagrophytes genotype VII diagnosed in Italy and characterized using whole genome sequencing. Skin scale samples were collected from genital/perigenital lesions and processed for mycological culture, antifungal susceptibility testing, and genomic analysis. Internal transcribed spacer (ITS) region sequencing confirmed the identification of genotype VII in all isolates. Phylogenetic analysis based on ITS sequences and phylogenomic analysis based on core genome single nucleotide polymorphisms consistently showed that the three isolates clustered within the genotype VII lineage and were closely related to previously described European strains. Antifungal susceptibility testing revealed low Minimum Inhibitory Concentration (MIC) values for extended-spectrum triazoles (voriconazole and posaconazole) and amphotericin B. Genomic analysis demonstrated that all isolates carried the wild-type SQLE gene, with no mutations associated with terbinafine resistance. Sequence variations were observed in several members of the MEP protease gene family and in the ZafA transcription factor gene. These findings confirm the presence of sexually transmitted T. mentagrophytes genotype VII in Italy and support the hypothesis that this genotype is an emerging cause of dermatophytosis in Europe. The integration of genomic approaches with clinical and epidemiological data may improve the understanding of transmission dynamics and help identify potential outbreaks.
Retrospective study of Acanthamoeba keratitis: Three-year experience with an integrated clinical and diagnostic workflow Margherita Ortalli, Antonio Moramarco, Piera Versura, Giovanna Liguori, Giuseppe Russello, Simone Ambretti, Simone Baiocchi, Giacomo Nigrisoli, Michele Potenza, Luigi Fontana, Tiziana Lazzarotto Diagnostic Microbiology and Infectious Disease, 2026 Acanthamoeba keratitis (AK) is a rare but sight-threatening corneal infection, caused by free-living protozoa of the genus Acanthamoeba. Although cases are rising in high-income countries, the nonspecific presentation and overlapping features with other keratitis frequently result in misdiagnosis of AK, with poorer outcomes and impaired quality of life. A delayed diagnosis can allow the infection to progress to deeper corneal layers, increasing the risk of severe structural damage and requiring emergency keratoplasty to preserve ocular integrity and regain vision. This retrospective study describes a three-year experience at a Northern Italy tertiary center using an integrated diagnostic workflow combining clinical evaluation, in vivo confocal microscopy, culture, and -since 2024- real-time PCR. Among 39 patients with suspected AK, 11 cases were confirmed. Culture showed 92 % sensitivity in first diagnoses but decreased to 77 % when relapses were included. PCR, introduced as a routine tool in 2024, showed 100 % sensitivity in first diagnoses and proved crucial in detecting low-burden or culture-negative relapses. Confocal microscopy reached a sensitivity and specificity of 82 %. Early targeted anti-amoebic therapy, guided by this integrated approach, contributed to favorable outcomes in most cases, limiting the need for surgical intervention. These findings support the utility of combining methods for timely and accurate diagnosis of AK. Despite ongoing challenges in the clinical management of AK, our findings reinforce the critical value of adopting molecular diagnostics to enable earlier, more accurate identification and targeted treatment.
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction? Pier Giorgio Cojutti, Renato Pascale, Andrea Grechi, Simone Ambretti, Pierluigi Viale, Federico Pea Antibiotics, 2026 Background: Staphylococcal bloodstream infections (BSIs) and infective endocarditis (IE) are associated with high morbidity and mortality. Among the different antimicrobial combination strategies proposed to enhance antibacterial activity, the association of daptomycin and ceftobiprole may be valuable. The aim of this study was to assess the PK/PD target attainment, safety, and clinical outcomes of such combination therapy for BSI and IE treatment. Methods: This retrospective monocentric study included adult patients with targeted treatment of staphylococcal BSI or IE with daptomycin plus continuous infusion (CI) ceftobiprole. Therapeutic drug monitoring (TDM) was performed for both agents, including Bayesian estimation of daptomycin 24 h area under the concentration–time curve (AUC24h). PK/PD targets were defined as daptomycin AUC24h/MIC ≥ 666 and ≥1081, and ceftobiprole steady-state concentration/MIC ≥ 4. Dose adjustments, safety, microbiological response, and clinical outcomes were assessed. Results: Twenty-three patients (11 BSI and 12 IE) were included. Methicillin-resistant Staphylococci were identified in 91.3% of cases. At first TDM assessment, daptomycin PK/PD targets were achieved in all patients, while ceftobiprole targets were achieved in 91.6% of BSI cases and in all IE cases. PK-/PD-guided dose de-escalation was frequently feasible. Clinical cure was observed in 77.8% of evaluable patients with BSI and in 91.7% with IE. Creatine phosphokinase elevations occurred in two patients, while hyper-eosinophilia was observed in 69.6% and was manageable with monitoring. Conclusions: Targeted therapy with daptomycin plus CI ceftobiprole achieved high PK/PD target attainment and favorable clinical outcomes in staphylococcal BSI and IE. TDM and model-informed precision dosing may enable dose optimization and may improve the balance between efficacy and safety. Multicenter studies are warranted.
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients Milo Gatti, Matteo Rinaldi, Cristiana Laici, Simone Ambretti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea Journal of Antimicrobial Chemotherapy, 2026 Objectives To assess the biliary pharmacokinetic/pharmacodynamic (PK/PD) of continuous infusion (CI) ceftazidime–avibactam in a series of critical orthotopic liver transplant (OLT) recipients having pre-emptive therapy during OLT because of carbapenemase-producing Enterobacterales (CPE) rectal colonization or targeted therapy of CPE intra-abdominal (IAIs) and/or biliary tract infections (BTIs). Methods We performed an exploratory, hypothesis-generating prospective case series including critical OLT recipients carrying a Kehr’s tube and undergoing therapeutic drug monitoring of ceftazidime and avibactam in both bile and plasma simultaneously while receiving CI ceftazidime–avibactam pre-emptive or targeted therapy. Biliary aggressive joint PK/PD target attainment [defined as a free ceftazidime steady-state concentrations fCss/MIC ratio >4 coupled with an avibactam fCss/target concentration (CT = 4 mg/L) ratio >1] was selected as optimal threshold of ceftazidime–avibactam efficacy, given this was previously shown to be independently associated with lower rates of microbiological failure and resistance development. Bile-to-plasma fCss ratios were calculated. Results Overall, four critical OLT recipients were included. Aggressive biliary ceftazidime–avibactam joint PK/PD target during treatment with CI 2 g/0.5 g q8 h over 8 h was attained in 2/4 cases (quasi-optimal and suboptimal in one case each). Median (range) fCss bile-to-plasma ratios were 0.28 (0.22–0.38) for ceftazidime and 0.24 (0.11–0.52) for avibactam. Conclusions Our limited cases series suggested that both ceftazidime and avibactam showed a moderate and broadly similar biliary penetration. Administration by CI may be helpful in attaining an aggressive biliary joint PK/PD target of ceftazidime–avibactam against pathogens with an MIC up to 8 mg/L.
What Is the Impact of Anti-Enterococcal Empirical Therapy on Survival of Patients with Enterococcal Bloodstream Infections? Linda Bussini, Davide F Bavaro, Enrico Brunetta, Francesco Carella, Stefano Accornero, Elena Rosselli del Turco, Zeno Pasquini, Kristian Scolz, Sara Tedeschi, Renato Pascale, Simone Ambretti, Isabella Banchini, Juan M Pericàs, Paula Hernández, Sulamita Carvalho-Brugger, Debora Mondatore, Maddalena Casana, Valeria Cento, Maddalena Giannella, Pierluigi Viale, Michele Bartoletti, , Linda Bussini, Renato Pascale, Juan M Pericas, Maddalena Giannella, Michele Bartoletti Clinical Infectious Diseases, 2026 Background The impact of early administration of active anti-enterococcal empirical therapy (EET) on outcomes of patients with enterococcal bloodstream infections (EBSIs) is unclear. We compared the outcome of patients with EBSIs receiving or not empirical therapy targeting Enterococcus spp. Methods A retrospective multicenter study enrolling all hospitalized patients with monomicrobial EBSIs during 2011–2019. The exposure variable was considered receiving EET defined as administration of antibiotic(s) active in vitro against Enterococcus spp isolated from index blood cultures (BCs) ≤48 hours from collection. The primary outcome was 14- and 30-day all-cause mortality from index BC. The impact of EET on mortality was assessed by Kaplan–Meier curves and multivariable Cox regression after adjustment with inverse probability treatment weighting (IPTW). Post hoc analysis explored the effect of EET given ≤24 hours from EBSI onset. Results Overall, 758 patients (male, 62%; median age, 71 years) had EBSIs and 342 received EET; 14- and 30-day mortality was 24% and 42%, respectively. After IPTW adjustment, a higher number of comorbidities and EBSIs without an identified source but not EET were independent predictors of 14- and 30-day mortality. No significant mortality risk reduction was associated with EET in the real or the IPTW-adjusted analysis. In the subgroup analysis, EET reduced 14-day mortality only in patients with vancomycin-resistant EBSIs. Even among 237 (31%) patients receiving EET <24 hours from EBSI onset, EET did not affect survival. Conclusions Early administration of EET may not have a prognostic impact in patients with EBSIs. Delivering EET might affect short-term survival only in patients with vancomycin-resistant EBSIs.
Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective Study Matteo Rinaldi, Russell Edward Lewis, Maria Chiara Susini, Bianca Nuti, Martina Casarini, Daniele Riccucci, Irene Grassi, Alice Toschi, Michele Bartoletti, Linda Bussini, Davide Fiore Bavaro, Valeria Cento, Lucia Diella, Alessandra Belati, Alessandro De Angelis, Diletta Barbanotti, Giulia Pensalfine, Simone Ambretti, Greta Roncarati, Pierluigi Viale, Maddalena Giannella Open Forum Infectious Diseases, 2026
Rapid AST in practice - a workflow analysis of the QuickMIC® rapid AST system at multiple clinical laboratories in Europe Amanda Kindvall Åhman, Victor Englöf, Kajsa Knagge, Lucas Reibenspies, Maria Avolio, Patricia Cabral da Silva, Patrizia Cambieri, Cristina Costa, Adriana Coutinho, Monica Dotta, Pier Andrea Dusi, Danielle Fenwick, Giorgia Gregori, Sandra Grunewald, Kerry Laws, Giuliana Lo Cascio, Paulo Lopes, Emma Marrs, Luis Morais, Joni Mota, Loredana Pangaro, Micaela Pelagi, Sara Petersson, Damiano Picicco, Tamara Ruegamer, Sarah Shodunke, Annika Wistedt, Hanna Woksepp, Andrea Zappavigna, Giuliana Germinario, Alessia Cantiani, Simone Ambretti, Cecilia Johansson, Anna Olsson, Christer Malmberg Frontiers in Cellular and Infection Microbiology, 2026
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections Cecilia Bonazzetti, Ettore Rocchi, Alice Toschi, Nicolas Riccardo Derus, Claudia Sala, Renato Pascale, Matteo Rinaldi, Caterina Campoli, Zeno Adrien Igor Pasquini, Beatrice Tazza, Armando Amicucci, Milo Gatti, Simone Ambretti, Pierluigi Viale, Gastone Castellani, Maddalena Giannella Npj Digital Medicine, 2025
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus Vittorio Sambri, Vanni Agnoletti, Simone Ambretti, Michele Bartoletti, Paola Bernaschi, Elena Giovanna Bignami, Stefano Busani, Caterina Campoli, Edoardo Carretto, Fausto Catena, Irene Coloretti, Monica Cricca, Gennaro De Pascale, Francesco Giuseppe De Rosa, Carla Fontana, Giovanni Gherardi, Maddalena Giannella, Massimo Girardis, Nicasio Mancini, Alessandra Oliva, Mauro Podda, Ornella Piazza, Federica Portunato, Venerino Poletti, Giulio Viceconte, Andrea Rocchetti, Domenico Pietro Santonastaso, Francesca Serapide, Stefania Stefani, Carlo Tascini, Gianpiero Tebano, Martina Tosi, Mario Tumbarello, Bruno Viaggi, Pierluigi Viale, Francesco Cristini, Matteo Bassetti, Marco Falcone, Ivan Gentile, Luca Gobbi, Giacomo Grasselli, Anna Teresa Palamara, Gianmaria Rossolini, Alessandro Russo, Maurizio Sanguinetti, Massimo Sartelli, Tommaso Tonetti Clinical Microbiology and Infection, 2025
Incidence of hospital-acquired infections due to carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study Gennaro De Pascale, Andrea Cortegiani, Matteo Rinaldi, Massimo Antonelli, Sergio Cattaneo, Maurizio Cecconi, Raffaele Cuffaro, Lidia Dalfino, Filomena Di Biase, Abele Donati, Francesca Romana Fasano, Teresa Fasciana, Giuseppe Foti, Antonella Frattari, Roberto Fumagalli, Massimo Girardis, Leonardo Gottin, Alessia Mattei, Marta Milazzo, Giorgia Montrucchio, Daniela Pasero, Fabio Picciafuochi, Emanuela Sensi, Giuseppe Servillo, Maria Alejandra Vidal Pereira, Teresa Spanu, Pierluigi Viale, , Salvatore Lucio Cutuli, Eloisa Sofia Tanzarella, Simone Carelli, Luca Montini, Antonino Giarratano, Romina Aceto, Erminia Casari, Luca Brazzi, Antonio Curtoni, Lucia Serio, Filippo Ferrari, Vincenzo Savini, Matteo Taiana, Annarita Mazzariol, Simone Ambretti, Grazia Merola, Linda Degl’Innocenti, Renato Ricciardi, Giovanni Gherardi, Fernando Arnaiz Guerrero, Chiara Vismara, Elena Vittorielli, Erika Casarotta, Maria Vargas, Roberto Rona, Annalisa Cavallero, Angela Muroni, Salvatore Rubino, Bruno Viaggi, Tommaso Giani, Mariachiara Ippolito, Beatrice Tiri, Stefano Cappanera, Alessandro Mariottini, Monica Stufano, Adriana Mosca, Giacomo Monti, Fabio Buffoli Critical Care, 2025
Evaluation of a digital remote extraction analysis and monitoring tool for key performance indicators (KPIs) in the blood culture process Claudio Palmieri, Laura Bartolini, Andrea Berlingeri, Barbara Camilloni, Gianfranco La Bella, Michela Pascarella, Marina Selleri, Felice Valzano, Chiara Vismara, Simone Ambretti, Carla Fontana, Mario Rassu, Gian Maria Rossolini, Fabio Arena, Antonella Mencacci, , Fabio Arena, Giulia Menchinelli, Marta Argentieri, Paola Bernaschi, Carla Fontana, Massimo Giusti, Flora Marzia Liotti, Giovanni Lorenzin, Antonella Mencacci, Cinzia Peronace, Mario Rassu, Teresa Spanu, Bruno Viaggi, Teresa Lopizzo European Journal of Clinical Microbiology and Infectious Diseases, 2025
Implementation of a Bundle for the Management of Patients with Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study Cecilia Bonazzetti, Andrea Grechi, Dino Gibertoni, Ludovica Mangione, Fulvia Todisco, Matteo Tonnini, Fabio Piscaglia, Paolo Caraceni, Pietro Calogero, Claudio Borghi, Giovanni Barbara, Natascia Caroccia, Matteo Rinaldi, Renato Pascale, Beatrice Tazza, Alice Toschi, Armando Amicucci, Caterina Campoli, Zeno Pasquini, Federica Calò, Simone Ambretti, Pierluigi Viale, Maddalena Giannella, , Giuseppe Ferraro, Federica Cosentino, Teresa Miani, Giacomo Beci, Michele Cantini, Maria Clara Chionsini, Irene Grassi, Marta Malosso, Giulia Menotti, Beatrice Miani, Filippo Miselli, Riccardo Pasquali, Anna Pozzi, Riccardo Riccardi, Daniele Riccucci, Valeria Viscusi, Manuel Zagarrigo, Alberto Zuppiroli, Roberta Capozzi, Assunta Cocchiarella, Pietro Fait, Caterina Gatto, Maria Eugenia Giacomini, Alessia Krawczyk, Francesco Marrella, Matteo Montironi, Carolina Patrucco, Alberto Pecorelli, Beatrice Profiti, Dario Santoro, Ilaria Sartini, Oana Vatamanu, Giacomo Ambrosi, Samantha Babini, Michele Bacchiega, Simone Boccia, Chiara Calgarini, Agnese Poma, Maria Teresa Presutti, Carlotta Sgarella, Lorenzo Santangelo, Michela di Chiara, Francesca Simone, Chiara Faggiano, Alessandro Venturi Open Forum Infectious Diseases, 2025
A European survey on anaerobes from paediatric blood cultures: a comparative analysis with adults Matteo Boattini, Arianna Aceti, Paulo Bastos, Viktoria Eirini Mavromanolaki, Sofia Maraki, Anastasia Spiliopoulou, Vasileios Kakouris, Yordan Kalchev, Ana Budimir, Branka Bedenić, Zana Rubic, Monica Licker, Corina Musuroi, Emese Juhász, Katalin Kristóf, Mateja Pirs, Ivana Velimirovic, Michael Berktold, Adriána Liptáková, Adriana Krajčíková, Pavel Drevinek, Anezka Gryndlerova, Monika Brzychczy-Wloch, Aldona Olechowska-Jarząb, Filip Bielec, Małgorzata Brauncajs, Edyta Podsiadly, Grażyna Nurzyńska, Patrycja Zalas-Więcek, Anna Michalska, Kristian Riesbeck, Hanna-Sofia Andersson, Tone Tønjum, Johan Christian Berild, Truls Michael Leegaard, Asger Nellemann Rasmussen, Kristian Schønning, Stefan Glöckner, Jürgen Rödel, Mohamed Tarek Badr, Georg Alexander Häcker, Denise Stark, Axel Hamprecht, Anna Dudakova, Jonathan Jantsch, Stefano Mancini, Chantal Quiblier, Damien Jacot, Gilbert Greub, Tiziano Ferniani, Simone Ambretti, Maddalena Calvo, Stefania Stefani, Rogier Schade, Erlangga Yusuf, Stefanie van Kleef - van Koeveringe, Sarah Vandamme, Alexia Verroken, Hector Rodriguez-Villalobos, François Duigou, Stéphane Corvec, Pauline Floch, Clémence Massip, Delphine Chainier, Olivier Barraud, Marie-Bossuète Louissaint, Assaf Mizrahi, Saied Ali, Maeve Doyle, Clarice Egan, Sinead McNicholas, Javier Colomina-Rodriguez, Ignacio Torres, Raul Gillaranz Luengo, Maria Nieves Larrosa Escartín, Maria Belen Viñado Perez, Ana Verónica Halperin, Sergio Fuente García, Rafael Cantón, Miguel Seruca, Vasco Santos Mendes, Dinah Carvalho, Rossana Cavallo, José Melo Cristino, Cristina Costa, Gabriele Bianco European Journal of Clinical Microbiology and Infectious Diseases, 2025
Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project Elisa Moreno-Mellado, Abdullah Tarik Aslan, Murat Akova, Eva León, Nicolás Merchante, David Vinuesa, Encarnación Moral-Escudero, Svetlana Sadyrbaeva-Dolgova, Salvador López-Cárdenas, Ángela Cano-Yuste, Matteo Rinaldi, María Núñez-Núñez, Maddalena Giannella, Jesús Sojo-Dorado, Ana Cristina Antolí-Royo, Natalia Chacón, Vicente Merino-Bohórquez, Inés Portillo, Jesús Rodríguez-Baño, Fernando Docobo-Pérez, Belén Gutiérrez-Gutiérrez, Virginia Palomo, David Gutiérrez, Sandra de la Rosa, Cansu Duran Zeynep, Ana I. Aller, Emilio Guirao Arrabal, Alicia Hernández-Torres, Elisa García-Vázquez, Carmen Hidalgo, Juan Pasquau, Julia Guzmán-Puche, Lourdes Ruiz-Sánchez de Puerta, Pierluigi Viale, Simone Ambretti, María del Carmen Martínez-Jiménez, María Ángeles Garcinuño-Jiménez Clinical Microbiology and Infection, 2025
Emergence of Salmonella enterica carrying blaOXA-181 carbapenemase gene, Italy, 2021 to 2024 Luca Bolzoni, Erika Scaltriti, Chiara Bracchi, Sara Angelone, Ilaria Menozzi, Roberta Taddei, Patricia Alba, Virginia Carfora, Elena Lavinia Diaconu, Marina Morganti, Alessandra Dodi, Melissa Berni, Laura Manni, Massimiliano Vinci, Martina Tambassi, Laura Mazzera, Irene Venturelli, Simone Ambretti, Antonio Battisti, Stefano Pongolini Eurosurveillance, 2025
A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY) Nicholas Geremia, Gianfranco Sanson, Luigi Principe, Roberta Maria Antonello, Verena Zerbato, Roberto Luzzati, Alberto Enrico Maraolo, Daniele Roberto Giacobbe, Chiara Sepulcri, Simone Ambretti, Richard Aschbacher, Laura Bartolini, Mariano Bernardo, Alessandra Bielli, Marina Busetti, Davide Carcione, Giulio Camarlinghi, Edoardo Carretto, Tiziana Cassetti, Chiara Chilleri, Francesco Giuseppe De Rosa, Saveria Dodaro, Raffaele Gargiulo, Francesca Greco, Anna Knezevich, Jari Intra, Tommaso Lupia, Erika Concialdi, Gabriele Bianco, Francesco Luzzaro, Carola Mauri, Gianluca Morroni, Adriana Mosca, Elisabetta Pagani, Eva Maria Parisio, Claudio Ucciferri, Chiara Vismara, Stefano Di Bella Anaerobe, 2024
Human Campylobacter spp. infections in Italy Verena Zerbato, Stefano Di Bella, Riccardo Pol, Roberto Luzzati, Gianfranco Sanson, Simone Ambretti, Stefano Andreoni, R. Aschbacher, Mariano Bernardo, Alessandra Bielli, Gioconda Brigante, M. Busetti, Giulio Camarlinghi, Davide Carcione, Antonella Carducci, Nicola Clementi, E. Carretto, Chiara Chilleri, Giulia Codda, Alessandra Consonni, Venera Costantino, Venere Cortazzo, Manuela Di Santolo, S. Dodaro, Barbara Fiori, A. García-Fernández, Claudio Foschi, E. Gobbato, Francesca Greco, Roberto M. La Ragione, Nicasio Mancini, A. Maraolo, Anna Marchese, D. Marcuccio, R. Marrollo, Carola Mauri, A. Mazzariol, G. Morroni, A. Mosca, Giacomo Nigrisoli, E. Pagani, Eva Maria Parisio, S. Pollini, M. Sarti, Annarita Sorrentino, Domenico Trotta, Laura Villa, C. Vismara, Luigi Principe European Journal of Clinical Microbiology and Infectious Diseases, 2024
Evaluation of an automated rapid phenotypic antimicrobial susceptibility testing (ASTar, Q-linea AB) applied directly on blood cultures bottles positive for Gram-negative pathogens New Microbiologica, 2024
Potential value of a rapid syndromic multiplex PCR for the diagnosis of native and prosthetic joint infections: a real-world evidence study Stéphanie Pascual, Brooklyn Noble, Nusreen Ahmad-Saeed, Catherine Aldridge, Simone Ambretti, Sharon Amit, Rachel Annett, Shaan Ashk O'Shea, Anna Maria Barbui, Gavin Barlow, Lucinda Barrett, Mario Berth, Alessandro Bondi, Nicola Boran, Sara E. Boyd, Catarina Chaves, Martin Clauss, Peter Davies, Ileana T. Dianzo-Delgado, Jaime Esteban, Stefan Fuchs, Lennart Friis-Hansen, Daniel Goldenberger, Andrej Kraševac Glaser, Juha O. Groonroos, Ines Hoffmann, Tomer Hoffmann, Harriet Hughes, Marina Ivanova, Peter Jezek, Gwennan Jones, Zeynep Ceren Karahan, Cornelia Lass-Flörl, Frédéric Laurent, Laura Leach, Matilde Lee Horsbøll Pedersen, Caroline Loiez, Maureen Lynch, Robert J. Maloney, Martin Marsh, Olivia Milburn, Shanine Mitchell, Luke S. P. Moore, Lynn Moffat, Marianna Murdjeva, Michael E. Murphy, Deepa Nayar, Giacomo Nigrisoli, Fionnuala O'Sullivan, Büşra Öz, Teresa Peach, Christina Petridou, Mojgan Prinz, Mitja Rak, Niamh Reidy, Gian Maria Rossolini, Anne-Laure Roux, Patricia Ruiz-Garbajosa, Kordo Saeed, Llanos Salar-Vidal, Carlos Salas Venero, Mathyruban Selvaratnam, Eric Senneville, Peter Starzengruber, Ben Talbot, Vanessa Taylor, Rihard Trebše, Deborah Wearmouth, Birgit Willinger, Marjan Wouthuyzen-Bakker, Brianne Couturier, Florence Allantaz Journal of Bone and Joint Infection, 2024
Increasing Number of Cases Due to Candida auris in North Italy, July 2019–December 2022 Camilla Sticchi, Roberto Raso, Lorenza Ferrara, Elena Vecchi, Loredana Ferrero, Daniela Filippi, Giuseppe Finotto, Elena Frassinelli, Carlo Silvestre, Susanna Zozzoli, Simone Ambretti, Giuseppe Diegoli, Carlo Gagliotti, Maria Luisa Moro, Enrico Ricchizzi, Fabio Tumietto, Francesca Russo, Michele Tonon, Francesco Maraglino, Giovanni Rezza, Michela Sabbatucci Journal of Clinical Medicine, 2023
Characterization of Gardnerella vaginalis isolates: correlations among clades, biofilm formation and cytokine stimulation New Microbiologica, 2023
Escherichia coli Is Overtaking Group B Streptococcus in Early-Onset Neonatal Sepsis Francesca Miselli, Riccardo Cuoghi Costantini, Roberta Creti, Francesca Sforza, Silvia Fanaro, Matilde Ciccia, Giancarlo Piccinini, Vittoria Rizzo, Lorena Pasini, Giacomo Biasucci, Rossella Pagano, Mariagrazia Capretti, Mariachiara China, Lucia Gambini, Rita Maria Pulvirenti, Arianna Dondi, Marcello Lanari, MariaFederica Pedna, Simone Ambretti, Licia Lugli, Luca Bedetti, Alberto Berardi Microorganisms, 2022
Machine learning-based typing of Salmonella enterica O-serogroups by the Fourier-Transform Infrared (FTIR) Spectroscopy-based IR Biotyper system Miriam Cordovana, Norman Mauder, Olivier Join-Lambert, François Gravey, Simon LeHello, Michel Auzou, Monica Pitti, Simona Zoppi, Michael Buhl, Joerg Steinmann, Hagen Frickmann, Denise Dekker, Yumiko Funashima, Zenzo Nagasawa, József Soki, László Orosz, Alida C. Veloo, Ulrik S. Justesen, Hanne M. Holt, Andrea Liberatore, Simone Ambretti, Stefano Pongolini, Laura Soliani, Andreas Wille, Sandra Rojak, Ralf Matthias Hagen, Jürgen May, A.B. Pranada, Markus Kostrzewa Journal of Microbiological Methods, 2022
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study Linda Bussini, Elena Rosselli Del Turco, Zeno Pasquini, Kristian Scolz, Alberto Amedeo, Giacomo Beci, Maddalena Giglia, Sara Tedeschi, Renato Pascale, Simone Ambretti, Juan M Pericàs, Maddalena Giannella, Sulamita Carvalho-Brugger, Laura Gutiérrez, Pierluigi Viale, Michele Bartoletti Journal of Global Antimicrobial Resistance, 2022
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey Stefano Di Bella, Roberta Maria Antonello, Gianfranco Sanson, Alberto Enrico Maraolo, Daniele Roberto Giacobbe, Chiara Sepulcri, Simone Ambretti, Richard Aschbacher, Laura Bartolini, Mariano Bernardo, Alessandra Bielli, Marina Busetti, Davide Carcione, Giulio Camarlinghi, Edoardo Carretto, Tiziana Cassetti, Chiara Chilleri, Francesco Giuseppe De Rosa, Saveria Dodaro, Raffaele Gargiulo, Francesca Greco, Anna Knezevich, Jari Intra, Tommaso Lupia, Erika Concialdi, Gabriele Bianco, Francesco Luzzaro, Carola Mauri, Gianluca Morroni, Adriana Mosca, Elisabetta Pagani, Eva Maria Parisio, Claudio Ucciferri, Chiara Vismara, Roberto Luzzati, Luigi Principe Anaerobe, 2022
Potential use of artificial intelligence for vaginal swab analysis in the assessment of common genital disorders: a pilot study New Microbiologica, 2022
The lower respiratory tract microbiome of critically ill patients with COVID-19 Paolo Gaibani, Elisa Viciani, Michele Bartoletti, Russell E. Lewis, Tommaso Tonetti, Donatella Lombardo, Andrea Castagnetti, Federica Bovo, Clara Solera Horna, Marco Ranieri, Pierluigi Viale, Maria Carla Re, Simone Ambretti Scientific Reports, 2021
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study Renato Pascale, Silvia Corcione, Linda Bussini, Livia Pancaldi, Daniele Roberto Giacobbe, Simone Ambretti, Tommaso Lupia, Cristina Costa, Anna Marchese, Francesco Giuseppe De Rosa, Matteo Bassetti, Claudio Viscoli, Michele Bartoletti, Maddalena Giannella, Pierluigi Viale BMC Infectious Diseases, 2021
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study Maddalena Giannella, Maristela Freire, Matteo Rinaldi, Edson Abdala, Arianna Rubin, Alessandra Mularoni, Salvatore Gruttadauria, Paolo Grossi, Nour Shbaklo, Francesco Tandoi, Alberto Ferrarese, Patrizia Burra, Ruan Fernandes, Luis Fernando Aranha Camargo, Angel Asensio, Laura Alagna, Alessandra Bandera, Jacques Simkins, Lilian Abbo, Marcia Halpern, Evelyne Santana Girao, Maricela Valerio, Patricia Muñoz, Ainhoa Fernandez Yunquera, Liran Statlender, Dafna Yahav, Erica Franceschini, Elena Graziano, Maria Cristina Morelli, Matteo Cescon, Pierluigi Viale, Russell Lewis, Michele Bartoletti, Renato Pascale, Caterina Campoli, Simona Coladonato, Francesco Cristini, Fabio Tumietto, Antonio Siniscalchi, Cristiana Laici, Simone Ambretti, Renato Romagnoli, Francesco Giuseppe De Rosa, Antonio Muscatello, Davide Mangioni, Andrea Gori, Barbara Antonelli, Daniele Dondossola, Giorgio Rossi, Federica Invernizzi, Maddalena Peghin, Umberto Cillo, Cristina Mussini, Fabrizio Di Benedetto, Débora Raquel Benedita Terrabuio, Carolina D Bittante, Alexandra do Rosário Toniolo, Elizabeth Balbi, José Huygens Parente Garcia, Ignacio Morrás, Antonio Ramos, Ana Fernandez Cruz, Magdalena Salcedo, and Clinical Infectious Diseases, 2021
Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing Christine C. Ginocchio, Carolina Garcia-Mondragon, Barbara Mauerhofer, Cory Rindlisbacher, the EME Evaluation Program Collaborative, L. Forcelledo, J. Fernández, R. Lienhard, H. Kerschner, G. M. Rossolini, L. Armand-Lefèvre, C. d’Humières, E. Cambau, H. Benmansour, R. Cavallo, M. Altwegg, L. Berlinger, R. Bonnet, P. Saint-Sardos, C. Meex, J. P. Lavigne, N. Leveque, L. Broutin, V. Cattoir, G. Auger, H. Pereira, Y. Paitan, A. Verroken, H. Pailhoriès, C. Lemarié, G. Martinetti-Lucchini, S. Frigerio Malossa, M. Sanguinetti, T. Spanu, F. Vandenesch, C. Poyart, J. Loubinoux, J. P. Mira, S. Bonacorsi, A. Cointe, P. Muñoz, M. Kestler, C. Esteva, X. Queralt, J. García-Rodríguez, M. D. Gómez, J. L. López-Hontangas, V. Ghisetti, E. Burdino, S. Schubert, A. Mencacci, F. Allegrucci, W. Rozemeijer, N. Paternotte, A. Allard, M. C. Re, S. Ambretti, M. Skov, C. N. Agergaard, P. Subudhi, T. A. Wichelhaus, A. Egli, V. Hinic, A. Alcock, K. Banavathi, C. Tiberio, G. Ruocco, L. Atripaldi European Journal of Clinical Microbiology and Infectious Diseases, 2021
Risk factors for group B streptococcus early-onset disease: an Italian, area-based, case-control study Alberto Berardi, Caterina Spada, Roberta Creti, Simone Ambretti, Rossana Chiarabini, Agostino Barozzi, Rossella Pagano, Mario Sarti, Maria Federica Pedna, Sara Fornaciari, Milena Azzalli, Icilio Dodi, Maria Letizia Bacchi Reggiani, Angela Lanzoni, Eleonora Vaccina, Lorenzo Iughetti, Laura Lucaccioni Journal of Maternal Fetal and Neonatal Medicine, 2020
Impact on mortality of a bundle for the management of enterococcal bloodstream infection Michele Bartoletti, Sara Tedeschi, Luigia Scudeller, Renato Pascale, Elena Rosselli Del Turco, Filippo Trapani, Fabio Tumietto, Giulio Virgili, Lorenzo Marconi, Stefano Ianniruberto, Matteo Rinaldi, Ilaria Contadini, Francesco Cristini, Linda Bussini, Caterina Campoli, Simone Ambretti, Andrea Berlingeri, Pierluigi Viale, Maddalena Giannella Open Forum Infectious Diseases, 2019
Epidemiology and complications of late-onset sepsis: An Italian area-based study Alberto Berardi, Francesca Sforza, Lorenza Baroni, Caterina Spada, Simone Ambretti, Giacomo Biasucci, Serenella Bolognesi, Mariagrazia Capretti, Edoardo Carretto, Matilde Ciccia, Marcello Lanari, Maria Federica Pedna, Vittoria Rizzo, Claudia Venturelli, Crisoula Tzialla, Laura Lucaccioni, Maria Letizia Bacchi Reggiani Plos One, 2019
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy G. Errico, C. Gagliotti, M. Monaco, L. Masiero, P. Gaibani, S. Ambretti, M.P. Landini, S. D’Arezzo, A. Di Caro, S.G. Parisi, G. Palù, F. Vespasiano, F. Morsillo, M.L. Moro, F. Procaccio, A. Ricci, P.A. Grossi, A. Pantosti, A. Nanni Costa, C. Farina, F. Vailati, G. Gesu, C. Vismara, M. Arghittu, R. Colombo, E. Torresani, L. Rossi, P.G. Conaldi, F. Gona, P. Cambieri, P. Marone, C. Venditti, A. Garcia Fernandez, C. Mancini, M. Cusi, L. Henrici De Angelis, L. Fossati, A.C. Finarelli, C. De Cillia, G. Sangiorgi, A.D. Pinna, F. Stella, P. Viale, M. Colledan, M. Platto, M. Bonizzoli, A. Peris, R. Torelli, S. Vesconi, E. Cibelli, L. De Carlis, A. De Gasperi, M. Ravini, R. Carrinola, E. Coluccio, D. Dondossola, G. Rossi, L. Santambrogio, D. Tosi, G. Feltrin, C. Rago, U. Cillo, A. Da Riva, F. Rea, V. Sparacino, A. Bertani, M. Canzonieri, B. Gridelli, A. Mularoni, M. Spada, E. Carrara, A. Maria D’Armini, P. Paladini, D. Adorno, M. Valeri, M. Caprio, P. Di Ciaccio, F. Puoti, P. Berloco, B. D’Auria, F. Maldarelli, G. Paglialunga, F. Pugliese, M. Rossi, F. Venuta, A. Amoroso, R. Giacometti, M. Rinaldi, M. Salizzoni Clinical Microbiology and Infection, 2019
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients M. Bartoletti, M. Giannella, R. Lewis, P. Caraceni, S. Tedeschi, M. Paul, C. Schramm, T. Bruns, M. Merli, N. Cobos-Trigueros, E. Seminari, P. Retamar, P. Muñoz, M. Tumbarello, P. Burra, M. Torrani Cerenzia, B. Barsic, E. Calbo, A.E. Maraolo, N. Petrosillo, M.A. Galan-Ladero, G. D'Offizi, N. Bar Sinai, J. Rodríguez-Baño, G. Verucchi, M. Bernardi, P. Viale, C. Campoli, G. Siccardi, S. Ambretti, A. Stallmach, M. Venditti, C. Lucidi, S. Ludovisi, M. De Cueto, M.D. Navarro, E. Lopez Cortes, E. Bouza, M. Valerio, A. Eworo, R. Losito, M. Senzolo, E. Nadal, A. Ottobrelli, M. Varguvic, C. Badia, G. Borgia, I. Gentile, A.R. Buonomo, E. Boumis, A. Beteta-Lopez, A. Rianda, G. Taliani, S. Grieco Clinical Microbiology and Infection, 2018
Infectious meningitis/encephalitis: Evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup New Microbiologica, 2018
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection Maddalena Giannella, Enrico Maria Trecarichi, Daniele Roberto Giacobbe, Francesco Giuseppe De Rosa, Matteo Bassetti, Alessandro Bartoloni, Michele Bartoletti, Angela Raffaella Losito, Valerio del Bono, Silvia Corcione, Sara Tedeschi, Francesca Raffaelli, Carolina Saffioti, Teresa Spanu, Gian Maria Rossolini, Anna Marchese, Simone Ambretti, Roberto Cauda, Claudio Viscoli, Russell Edward Lewis, Pierluigi Viale, Mario Tumbarello International Journal of Antimicrobial Agents, 2018
Infections in liver and lung transplant recipients: A national prospective cohort SInT Collaborative Study Group, Carlo Gagliotti, Filomena Morsillo, Maria Luisa Moro, Lucia Masiero, Francesco Procaccio, Francesca Vespasiano, Annalisa Pantosti, Monica Monaco, Giulia Errico, Andrea Ricci, Paolo Grossi, Alessandro Nanni Costa European Journal of Clinical Microbiology and Infectious Diseases, 2018
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department Pierluigi Viale, Sara Tedeschi, Luigia Scudeller, Luciano Attard, Lorenzo Badia, Michele Bartoletti, Alessandra Cascavilla, Francesco Cristini, Nicola Dentale, Giovanni Fasulo, Giorgio Legnani, Filippo Trapani, Fabio Tumietto, Gabriella Verucchi, Giulio Virgili, Andrea Berlingeri, Simone Ambretti, Chiara De Molo, Mara Brizi, Mario Cavazza, Maddalena Giannella Clinical Infectious Diseases, 2017
Antimicrobial stewardship in newborns and young infants: Why and how to do it Medico E Bambino, 2017
The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based study Alberto Berardi, Lorenza Baroni, Maria Letizia Bacchi Reggiani, Simone Ambretti, Giacomo Biasucci, Serenella Bolognesi, Maria Grazia Capretti, Edoardo Carretto, Matilde Ciccia, Valentina Fiorini, Cinzia Fortini, Giancarlo Gargano, Maria Federica Pedna, Vittoria Rizzo, Roberta Creti, Fabrizio Ferrari, on Behalf of the GBS Prevention Working Group Emilia-Romagna Journal of Maternal Fetal and Neonatal Medicine, 2016
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study Mario Tumbarello, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa, Maddalena Giannella, Daniele Roberto Giacobbe, Matteo Bassetti, Angela Raffaella Losito, Michele Bartoletti, Valerio Del Bono, Silvia Corcione, Giuseppe Maiuro, Sara Tedeschi, Luigi Celani, Chiara Simona Cardellino, Teresa Spanu, Anna Marchese, Simone Ambretti, Roberto Cauda, Claudio Viscoli, Pierluigi Viale, on behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva) Journal of Antimicrobial Chemotherapy, 2015
Use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to detect carbapenemase production in Enterobacteriaceae by a rapid meropenem degradation assay New Microbiologica, 2015
Staphylococcus aureus in a northern Italian region: Phenotypic and molecular characterization Carlo Gagliotti, Monica Monaco, Carla Sabia, Raffaele Gargiulo, Mario Sarti, Andrea Sanchini, Massimiliano Marchi, Simone Ambretti, Fabio Calanca, Carmelina Carillo, Antonio Paolo Cipolloni, Massimo Confalonieri, Claudia Di Carlo, Maria Federica Pedna, Lidia Ricci, Maria Rita Rossi, Silvia Storchi Incerti, Giovanna Testa, Claudia Venturelli, Annalisa Pantosti, Maria Luisa Moro Scandinavian Journal of Infectious Diseases, 2012
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: Surveillance period 1 March - 30 September 2010 Eurosurveillance, 2011
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-I from Italy New Microbiologica, 2010
Blood culture systems: rapid detection--how and why? Paolo Gaibani, Giada Rossini, Simone Ambretti, Francesco Gelsomino, Anna Maria Pierro, Stefania Varani, Michela Paolucci, Maria Paola Landini, Vittorio Sambri International Journal of Antimicrobial Agents, 2009
Prevention of iatrogenic transmission of B19 infection: Different approaches to detect, remove or inactivate virus contamination Clinical Laboratory, 2006
